Physician profile
Bonnie E Eady
NPI 1962664664
$1,737.97
in general payments reported to CMS, 2019-2025
24 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $76.64 · 2021: $231 · 2022: $401 · 2023: $263 · 2024: $91.06 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $257.97 | 2019-2025 | Lo Loestrin Fe |
| Bayer Healthcare Pharmaceuticals INC. | $200.36 | 2019-2023 | |
| Insmed, INC. | $145.41 | 2019 | |
| Avion Pharmaceuticals | $139.32 | 2019-2023 | Balcoltra |
| Exeltis, USA INC. | $126.33 | 2021-2025 | Slynd |
| Duchesnay USA Incorporated | $120.28 | 2019 | |
| Organon LLC | $110.30 | 2021-2025 | Nexplanon |
| Evofem Biosciences, INC. | $85.19 | 2021-2024 | Phexxi |
| Hologic Sales and Service, LLC | $77.58 | 2022-2025 | Aptima, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Vertical Pharmaceuticals, LLC | $60.19 | 2019-2020 | |
| Coopersurgical, INC. | $52.55 | 2021-2025 | Paragard T 380a |
| Pfizer INC. | $50.44 | 2019-2024 | |
| Shield Therapeutics INC | $47.63 | 2023-2025 | Accrufer |
| Sage Therapeutics, LLC | $46.44 | 2024-2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $42.87 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $38.05 | 2022 | |
| Mayne Pharma Commercial LLC | $21.33 | 2025 | |
| Astellas Pharma US INC | $20.00 | 2024 | Veozah |
| Baxter Healthcare | $18.99 | 2022 | |
| Agile Therapeutics, INC. | $18.45 | 2023 | Twirla |
| Boston Scientific Corporation | $16.17 | 2025 | General - Tachy |
| Allergan, INC. | $15.21 | 2019 | |
| Supernus Pharmaceuticals, INC. | $13.47 | 2025 | Qelbree |
| Minerva Surgical, INC | $13.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bonnie Eady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.